Insight
AI in M&A: 10 Things to Consider in Acquisitions
by Julia Apostle, Alexis Marraud des Grottes and Zac Padgett
9 minute read | September.18.2023

by Julia Apostle, Alexis Marraud des Grottes and Zac Padgett
9 minute read | September.18.2023
by Harry Clark, Jeanine P. McGuinness and Elizabeth Zane
5 minute read | August.14.2023
by Nicola Whiteley, Emma Zarb, Charlotte Oliver and Heather Hanlon
9 minute read | August.29.2023
by Richard F. Martinelli and Daniel Patrick Kearney
4 minute read | August.03.2023
by Annette Hurst, Daniel Yost, Ramin Tohidi, Sarah Schaedler and Daniel Healow
10 minute read | August.03.2023
by Jamie Moore, Kristy Hart, Alex Sobolev and Anna O'Kelly
9 minute read | September.28.2023
In the fifteenth installment of Orrick's Founder Series, we offer guidance on what founders should look out for when developing or using AI in the UK.
1 minute watch | March.26.2025
by Harry Clark, Jeanine P. McGuinness, Elizabeth Zane, Allison Lofgren Bradham, Maria Sergeyeva and Gregory I. Hume
3 minute read | February.24.2025
by Robert Loeb, Cesar Lopez-Morales, Ed Williams and Ramon J. Ryan
4 minute read | February.07.2025
by Georgia C. Ravitz, Shari Esfahani, Stephen Thau, Thora Johnson, Jeremy D. Sherer and Amy M. Joseph
2 minute read | January.13.2025
The FDA issued draft guidance on assessing AI model credibility for drug safety, effectiveness, and quality in regulatory decisions.
4 minute read | January.23.2025
by Thora Johnson, Alyssa Wolfington and Michaela Frai
6 minute read | January.27.2025